Journal
NEUROBIOLOGY OF AGING
Volume 25, Issue 8, Pages 1001-1007Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2003.11.003
Keywords
aging; Alzheimer's disease; brain; complement activation; ELISA; inflammation
Categories
Funding
- NIA NIH HHS [P50-AG08671] Funding Source: Medline
Ask authors/readers for more resources
Complement activation is increased in Alzheimer's disease (AD) and may contribute to the development and progression of this disorder. To compare early complement activation between normal and AD brain specimens, C4d and iC3b concentrations were measured in hippocampus, entorhinal cortex, temporal cortex, parietal cortex, and cerebellum from aged normal and AD subjects (n = 10-14 for both), and in hippocarnpus and entorhinal cortex from younger normal subjects (n = 5-6). C4d and iC3b levels increased 2.3- to 4.6-fold in AD versus aged normal specimens (all P < 0.05), with lowest concentrations of these activation proteins generally in cerebellum. No significant differences were present between aged and younger normal C4d and iC3b levels in hippocampus or entorhinal cortex. However, the concentrations of these proteins were markedly increased in several aged normal specimens. Normal subject age was moderately associated with both C4d (r = 0.49) and iC3b (r = 0.53) concentrations in the hippocampus. Increased brain complement activation in some elderly individuals may promote the subsequent development of AD. (C) 2003 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available